Your browser doesn't support javascript.
loading
Compliance with tetracycline eye ointment during annual mass drug administration for trachoma control in the Amhara region, Ethiopia.
Aragie, Solomon; Shiferaw, Ayalew; Sata, Eshetu; Hailu, Dagnachew; Dagnew, Adane; Zeru, Taye; Abebe, Adisu; Tadesse, Zerihun; Wittberg, Dionna M; Thompson, Isabel J B; Lietman, Thomas M; Nash, Scott D; Jensen, Kimberly A; Callahan, E Kelly; Keenan, Jeremy D.
Afiliação
  • Aragie S; The Carter Center Ethiopia, Addis Ababa, Ethiopia.
  • Shiferaw A; Francis I Proctor Foundation, University of California, San Francisco, California, USA.
  • Sata E; The Carter Center Ethiopia, Addis Ababa, Ethiopia.
  • Hailu D; The Carter Center Ethiopia, Addis Ababa, Ethiopia.
  • Dagnew A; The Carter Center Ethiopia, Addis Ababa, Ethiopia.
  • Zeru T; The Carter Center Ethiopia, Addis Ababa, Ethiopia.
  • Abebe A; Amhara Public Health Institute, Bahir Dar, Ethiopia.
  • Tadesse Z; Amhara Regional Health Bureau, Bahir Dar, Ethiopia.
  • Wittberg DM; The Carter Center Ethiopia, Addis Ababa, Ethiopia.
  • Thompson IJB; Francis I Proctor Foundation, University of California, San Francisco, California, USA.
  • Lietman TM; Francis I Proctor Foundation, University of California, San Francisco, California, USA.
  • Nash SD; Francis I Proctor Foundation, University of California, San Francisco, California, USA.
  • Jensen KA; Department of Ophthalmology, University of California, San Francisco, California, USA.
  • Callahan EK; The Carter Center, Atlanta, Georgia, USA.
  • Keenan JD; The Carter Center, Atlanta, Georgia, USA.
Trop Med Int Health ; 2024 Aug 14.
Article em En | MEDLINE | ID: mdl-39142662
ABSTRACT

OBJECTIVES:

A 6-week course of tetracycline eye ointment is an alternative to single -dose oral azithromycin in annual mass drug administration for trachoma control. Compliance with the recommended tetracycline eye ointment regimen has not been well characterised when administered as part of a trachoma control program.

METHODS:

A routine mass drug administration for trachoma was carried out in 40 communities in the Amhara region of Ethiopia. Two tubes of tetracycline eye ointment, to be administered twice daily for 6 weeks, was offered to all children under 6 months of age, to pregnant women who declined to take azithromycin, and to all individuals with a macrolide allergy. Seven weeks following the mass drug administration, a treatment compliance survey was performed for all community members documented to have received tetracycline eye ointment during the mass drug administration.

RESULTS:

Of the 491 individuals documented as having received tetracycline eye ointment from the treatment records, 367 completed the survey, of which 214 recalled being offered tetracycline eye ointment. A total of 105 (49%) respondents reported taking ≥1 daily dose of tetracycline eye ointment on most days of the week for at least the first week. Only 20 (9%) respondents reported taking at least 1 tetracycline eye ointment dose per week for 6 weeks. The most common reasons for low compliance included 'saving it for a future infection' and 'stopped because I (or my child) seemed healthy'. The odds of low compliance were greater for those who reported not having adequate counselling (e.g., odds ratio [OR] 5.3, 95% CI 2.5-28.9 when low compliance was defined as not taking a tetracycline eye ointment dose for most days of at least the first week).

CONCLUSIONS:

Compliance with tetracycline eye ointment was low when administered by a trachoma program during a routine mass drug administration, especially for those reporting inadequate counselling. Further research with a larger sample size and varied settings is warranted to better understand and improve compliance.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Ano de publicação: 2024 Tipo de documento: Article